One-touch embeddable microneedles for hair loss treatment.

Int J Pharm

Department of Biomaterials Science (BK21 Four Program), Life and Industry Convergence Institute, Pusan National University, Miryang 50463, Republic of Korea. Electronic address:

Published: December 2024

With increasing clinical demands for painless and easy administration of medications, such as for hair loss, microneedles (MNs) have been widely exploited for facilitating drug permeation in a minimally invasive manner. However, precise dose control and long-term drug delivery without the infection risk through punctured holes have remained unresolved. Herein, we developed swellable microneedles (MNs) with an air-pocket structure, enabling shear-induced implantation inside the skin. The air-pocket MNs (AP-MNs) were prepared by one-step molding process with genipin-crosslinked gelatin solutions. This MN design induced mechanical difference following insertion due to selective hydration at the inserted MN tips, causing them to break at the interface between the swollen tip and the non-inserted column. The AP-MNs (80-90 %) were embedded into the skin and played a barrier function by tightly sealing punctured holes. Minoxidil (MXD) for hair loss treatment were quantitatively loaded in the AP-MNs depending on swellable tip heights, with 90 % of loaded MXD in the AP-MN tips released over 48 h. In animal studies, the MXD-loaded AP-MNs exhibited higher efficiency than topical application for hair loss treatment. These results indicate that the design of shear-induced embeddable MNs could provide a high-efficiency, convenient, safe, and potentially self-administered method for drug delivery.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2024.125020DOI Listing

Publication Analysis

Top Keywords

hair loss
16
loss treatment
12
microneedles mns
8
drug delivery
8
punctured holes
8
one-touch embeddable
4
embeddable microneedles
4
hair
4
microneedles hair
4
loss
4

Similar Publications

Application of Ultraviolet-Induced Fluorescence Trichoscopy (UVFT) in Hair and Scalp Diseases.

Dermatol Ther (Heidelb)

January 2025

Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.

Introduction: Ultraviolet-induced fluorescence dermoscopy (UVFD) is increasingly utilized in dermatooncology and general dermatology. The objective of the study was to characterize the ultraviolet-induced fluorescence trichoscopy (UVFT) findings in a wide range of hair and scalp conditions.

Methods: Consecutive patients with non-scarring alopecias (alopecia areata, AA, n = 40; androgenetic alopecia, AGA, n = 40), scarring alopecias (frontal fibrosing alopecia, FFA, n = 20; lichen planopilaris, LPP, n = 20; folliculitis decalvans, FD, n = 14; discoid lupus erythematosus, DLE, n = 23), and inflammatory scalp conditions (psoriasis, n = 30; seborrheic dermatitis, n = 14) were included.

View Article and Find Full Text PDF

Background: Exposures to hazardous noise causes irreversible injury to the structures of the inner ear, leading to changes in hearing and balance function with strong links to age-related cognitive impairment. While the role of noise-induced hearing loss in long-term health consequences, such as progression or development of Alzheimer's Disease (AD) has been suggested, the underlying mechanisms and behavioral and cognitive outcomes or therapeutic solutions to mitigate these changes remain understudied. This study aimed to characterize the association between blast exposure, hearing loss, and the progression of AD pathology, and determine the underlying mechanisms.

View Article and Find Full Text PDF

Millions of men and women suffer from alopecia, especially androgenic alopecia (AGA), which is considered the most common form of hair loss. The available treatments for hair loss include multiple approaches, with the most popular being synthetic drugs including minoxidil and finasteride, in addition to natural products. However, synthetic drugs have shown many undesirable side effects, on the contrary, the specifications of the commonly used natural drugs have not been reported in most of the previous studies, despite the high market preference for them.

View Article and Find Full Text PDF

Nowadays androgenetic alopecia (AGA) has become a common concern of affected subjects of both sexes. Finasteride is approved by the Food and Drug Administration for the treatment of male AGA. There is no clear evidence to support the use of dutasteride in male AGA.

View Article and Find Full Text PDF

Olmsted syndrome is characterized by symmetrically distributed, destructive, inflammatory palmoplantar keratoderma with periorificial keratotic plaques, most commonly due to gain-of-function mutations in the transient receptor potential vanilloid 3 (TRPV3) gene, which involves multiple pathological functions of the skin, such as hyperkeratosis, dermatitis, hair loss, itching, and pain. Recent studies suggest that mutations of located in different structural domains lead to cases of varying severity, suggesting a potential genotype-phenotype correlation resulting from TRPV3 gene mutations. This paper reviews the genetics and pathogenesis of Olmsted syndrome, as well as the potential management and treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!